8-121622260-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The NM_005328.3(HAS2):​c.628-5054G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.198 in 152,032 control chromosomes in the GnomAD database, including 3,080 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3080 hom., cov: 31)

Consequence

HAS2
NM_005328.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0200

Publications

2 publications found
Variant links:
Genes affected
HAS2 (HGNC:4819): (hyaluronan synthase 2) Hyaluronan or hyaluronic acid (HA) is a high molecular weight unbranched polysaccharide synthesized by a wide variety of organisms from bacteria to mammals, and is a constituent of the extracellular matrix. It consists of alternating glucuronic acid and N-acetylglucosamine residues that are linked by beta-1-3 and beta-1-4 glycosidic bonds. HA is synthesized by membrane-bound synthase at the inner surface of the plasma membrane, and the chains are extruded through pore-like structures into the extracellular space. It serves a variety of functions, including space filling, lubrication of joints, and provision of a matrix through which cells can migrate. HA is actively produced during wound healing and tissue repair to provide a framework for ingrowth of blood vessels and fibroblasts. Changes in the serum concentration of HA are associated with inflammatory and degenerative arthropathies such as rheumatoid arthritis. In addition, the interaction of HA with the leukocyte receptor CD44 is important in tissue-specific homing by leukocytes, and overexpression of HA receptors has been correlated with tumor metastasis. HAS2 is a member of the newly identified vertebrate gene family encoding putative hyaluronan synthases, and its amino acid sequence shows significant homology to glycosaminoglycan synthetase (DG42) from Xenopus laevis, and human and murine hyaluronan synthase 1. [provided by RefSeq, Jul 2008]
HAS2 Gene-Disease associations (from GenCC):
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.212 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005328.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HAS2
NM_005328.3
MANE Select
c.628-5054G>C
intron
N/ANP_005319.1Q92819

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HAS2
ENST00000303924.5
TSL:1 MANE Select
c.628-5054G>C
intron
N/AENSP00000306991.4Q92819

Frequencies

GnomAD3 genomes
AF:
0.198
AC:
30043
AN:
151914
Hom.:
3076
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.236
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.249
Gnomad EAS
AF:
0.108
Gnomad SAS
AF:
0.138
Gnomad FIN
AF:
0.162
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.215
Gnomad OTH
AF:
0.215
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.198
AC:
30067
AN:
152032
Hom.:
3080
Cov.:
31
AF XY:
0.193
AC XY:
14344
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.190
AC:
7873
AN:
41478
American (AMR)
AF:
0.198
AC:
3027
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.249
AC:
862
AN:
3466
East Asian (EAS)
AF:
0.108
AC:
558
AN:
5176
South Asian (SAS)
AF:
0.138
AC:
665
AN:
4822
European-Finnish (FIN)
AF:
0.162
AC:
1717
AN:
10576
Middle Eastern (MID)
AF:
0.310
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
0.215
AC:
14600
AN:
67936
Other (OTH)
AF:
0.218
AC:
460
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1235
2469
3704
4938
6173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0936
Hom.:
124
Bravo
AF:
0.204
Asia WGS
AF:
0.145
AC:
505
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
18
DANN
Benign
0.78
PhyloP100
0.020
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.32
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.32
Position offset: -29

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6651224; hg19: chr8-122634500; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.